Chitosan-microcapsulated insulin alleviates mesenteric microcirculation dysfunction via modulating COX-2 and VCAM-1 expression in rats with diabetes mellitus
Jun Xu, Lijun Cao, Yuan Suo, Xiaoqin Xu, Hui Sun, Songao Xu, Xiangyun Zhu, Huijie Yu, Weizhong Cao Department of Emergency Medicine, The First Hospital of Jiaxing, Jiaxing 314001, Zhejiang Province, China Background: The study of the experiment was to display the therapeutic function of insulin-lo...
Guardado en:
Autores principales: | Xu J, Cao L, Suo Y, Xu X, Sun H, Xu S, Zhu X, Yu H, Cao W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5df83a796b824890b02b68e7da6735bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
VCAM-1 Is Upregulated in Uranium Miners Compared to Other Miners
por: Nour A. Ass’ad, et al.
Publicado: (2021) -
COX-2 Inhibitors in Dental Pain Management
por: Del-Muro-Casas,Fatima Erendida, et al.
Publicado: (2018) -
Serum levels of ICAM-I, VCAM, and Е-selectin in arterial hypertension with type 2 diabetes and obesity
por: L.A. Mogylnytska
Publicado: (2017) -
Pathomorphological diagnostics of chronic appendicitis (literature review)
por: N. N. Dremina, et al.
Publicado: (2017) -
Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation
por: Liu LY, et al.
Publicado: (2016)